Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) major shareholder Venture Opportunity Fund Atlas purchased 17,857 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The stock was bought at an average cost of $56.00 per share, for a total transaction of $999,992.00. Following the purchase, the insider now owns […]